• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2019, Vol. 21 ›› Issue (6): 589-591.DOI: 10.3969/j.issn.1671-2587.2019.06.009

Previous Articles     Next Articles

Clinical Application of Tuberculosis - Interferon Gamma Release Assay in The Diagnosis of Tuberculosis

YIN Mei-ling, LI Ming, CUI Hua-qin, et al   

  1. Department of Laboratory Diagnostics,Western Branch of The First Affiliated Hospital of University of Science and Technology of China,Anhui Provincial Cancer Hospital,Hefei,Anhui 230031
  • Received:2018-08-07 Online:2019-12-20 Published:2019-12-25

Abstract: Objective To evaluate the clinical value of tuberculosis-interferon gamma release assay (TB-IGRA) in the diagnosis of tuberculosis. Methods A retrospective analysis of the clinical data from 756 hospitalized patients,who received TB-IGRA test from Sep 2015 to Jun 2017,was performed. Results The positive rate of TB-IGRA was 87.31% in TB patients,and the positive rate of TB-IGRA was 85.55% and 90.80% respectively in the patients with pulmonary tuberculosis and extrapulmonary tuberculosis,significantly higher than that in the patients without tuberculosis (P<0.001); there was significantly higher detectable rate in TB patients by TB-IGRA than by anti-acid staining,detection of TB antibody, and the detection of ADA in hydrothorax and ascites (P<0.001); there were no statistical differences in the detection level of TB-IGRA between different ages,sex,basic diseases,tuberculosis sites,lymphocyte counts,and tuberculosis activity.Conclusion sTB-IGRA had higher diagnostic value in the detection of pulmonary tuberculosis and extrapulmonary tuberculosis. TB-IGRA can be used as auxiliary diagnosis of tuberculosis.

Key words: TB-IGRA, Anti-acid staining, TB-AB, ADA

CLC Number: